About ImpediMed
ImpediMed is a medical technology company specializing in bioimpedance spectroscopy (BIS) devices for non-invasive measurement of fluid status and tissue composition in both healthy and unhealthy patient populations. The company's flagship SOZO Digital Health Platform is the only FDA-cleared BIS technology that measures 256 frequencies in a single 30-second scan, separating intra- and extracellular fluid for accurate whole-body composition profiling. ImpediMed serves multiple healthcare specialties including cancer survivorship, heart health management, medical weight management, and wellness. The platform enables early detection of lymphedema in cancer patients, monitors fluid changes in heart failure patients, tracks muscle mass loss during GLP-1 therapy, and provides comprehensive body composition analysis. With cloud-connected capabilities through MySOZO, the platform delivers actionable data at the point of care with integrated EHR compatibility, enabling personalized, coordinated care across the patient treatment journey. The company's solutions include L-Dex Analysis for lymphedema, BodyComp Analysis for body composition, Segmental BodyComp Analysis for limb-specific measurements, and HF-Dex Analysis for heart failure fluid assessment. ImpediMed's technology is designed for seamless clinical workflow integration, providing clear reporting with thresholds, historical data, and longitudinal tracking to support informed clinical decision-making.
Mission & Story
Mission
Detect Early. Intervene Sooner. Achieve Better Outcomes.
Clinical Focus
Medical conditions and clinical areas addressed by ImpediMed.
Who It Serves
Milestones & Awards
Recent Milestones
Erik Anderson appointed as Chief Executive Officer (April 2026), Erik Anderson appointed to Board of Directors (February 2026), Broadened breast cancer survivorship monitoring at ASBrS 2026 (May 2026)
Awards & Recognition
NCCN Guidelines referenced, NAPBC Standards compliance
Key Partnerships
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 63 →
Acurable
Acurable creates accurate and user-friendly wearable medical devices for at-home monitoring of sleep apnea, epilepsy, COPD, and asthma.
Aktiia
Aktiia develops optical blood pressure monitoring technology integrated into wearable devices for continuous, cuffless blood pressure tracking. The company focuses on enabling remote patient monitoring and hypertension management through clinically validated wearable solutions.
August Health
August Health provides an AI-enabled EHR platform designed specifically for senior living communities. The platform includes integrated modules for electronic health records, medication management (eMAR), move-ins, billing, care tracking, and predictive analytics to help operators shift from reactive to proactive care strategies.
Babyscripts
Babyscripts is a market-leading digital maternity care platform that combines remote patient monitoring, care management, and patient engagement tools to improve maternal health outcomes across prenatal and postpartum care for health systems, payers, and private practices.
Belun Technology Company
11-50 employees
Belun Technology develops FDA-cleared AI-powered wearable ring technology for sleep apnea diagnosis and continuous health monitoring. The company provides medical-grade sleep diagnostics that bridge the gap between home and hospital care.
Binah.ai
Binah.ai provides an AI-powered, video-based, 100% software solution that enables measurement of vital signs and health indicators using smartphone or tablet cameras. In 35 seconds, users can measure vital signs, chronic disease risks, stress levels, and bloodless blood tests without wearables or equipment.
Biobeat
Biobeat develops FDA-cleared cuffless ambulatory blood pressure monitoring (ABPM) solutions using a wireless, non-invasive chest patch. The company enables 24-hour hypertension monitoring for cardiologists, nephrologists, and hypertension centers to improve diagnosis accuracy and treatment management.
Biofourmis
growth · 350 employees
Biofourmis provides a connected technology platform that partners with health systems, hospitals, and payers to revolutionize care delivery across the continuum.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.